Acadia Healthcare

Acadia Healthcare Company, Inc. is a for-profit behavioral healthcare provider headquartered in Franklin, Tennessee. Founded in 2005 by Reeve B. Waud, the company develops, acquires, and operates facilities treating mental illness, substance-use disorders, trauma, post-traumatic stress disorder, eating disorders, and related behavioral health conditions. Its services are delivered through inpatient psychiatric hospitals, residential programs, outpatient centers, comprehensive treatment centers, and specialized facilities serving children, adolescents, and adults. Acadia became a public company in 2011 and expanded substantially through acquisitions and partnerships with nonprofit hospital systems. Its partnership model allows Acadia to operate behavioral health facilities associated with established healthcare organizations, including systems such as Henry Ford Health, Geisinger, and Nebraska Methodist. Facilities may operate under the partner’s local brand while Acadia supplies operational management and behavioral-health expertise. The company’s growth has been supported by increased insurance coverage for mental healthcare following the Affordable Care Act, although its business model has also attracted scrutiny over patient admissions, billing practices, staffing, safety, and the relationship between occupancy, reimbursement, and clinical decision-making. A major part of Acadia’s U.S. portfolio is medication-assisted treatment for opioid-use disorder. In 2014, it acquired CRC Health, a large addiction-treatment provider, from Bain Capital. The acquisition gave Acadia a substantial network of opioid-treatment programs, including methadone clinics. By late 2024, the company was described as operating 165 methadone clinics in 33 states, making it the largest methadone-clinic chain in the United States. In addition to methadone, its treatment network provides counseling, medical assessment, medication management, and other services for substance-use disorders. Acadia also built an international presence in the United Kingdom. It acquired Partnerships in Care in 2014 and the mental-health assets of Care UK in 2015. Its UK expansion included psychiatric, rehabilitation, and social-care services, but competition concerns surrounding its proposed acquisition of Priory Group led to regulatory scrutiny and the subsequent sale of 22 behavioral-health facilities to BC Partners in 2016. The company has operated one of the largest dedicated behavioral-health networks in the United States. Public descriptions of its 2022 operations cited approximately 22,500 employees, about 70,000 patients in its daily census, and 242 facilities with roughly 10,800 beds across 39 states and Puerto Rico. Later descriptions of the network have emphasized more than 225 U.S. facilities, including more than 50 inpatient psychiatric hospitals and 165 methadone clinics. Facility totals vary by year, definition, acquisitions, divestitures, and operating status. Acadia’s brand is therefore primarily institutional rather than consumer-facing. It is positioned as a facility operator and behavioral-health infrastructure company, serving patients, families, insurers, public agencies, emergency departments, first responders, and hospital partners. The company has marketed direct access to its facilities as an alternative to emergency-room intake and has cultivated referral relationships with emergency departments and first responders. At the same time, investigations, government findings, lawsuits, settlements, and regulatory actions have made quality of care, patient rights, alleged improper detention, billing integrity, staffing, and child safety central parts of its public reputation.

Acadia Healthcare was established in 2005 as a private behavioral-health company by Reeve B. Waud. Its initial business focused on operating behavioral-health facilities, and the company subsequently pursued a growth strategy based on facility development, acquisitions, joint ventures, and management partnerships. Acadia went public in 2011 under the ticker ACHC, giving it access to public equity markets while retaining a business model centered on operating healthcare assets rather than manufacturing medical products. The company expanded in the United States as demand for psychiatric and addiction services increased and insurance coverage for mental-health treatment broadened after the Affordable Care Act. Acadia developed relationships with nonprofit hospital systems, including Henry Ford, Geisinger, and Nebraska Methodist. Under these arrangements, Acadia commonly operates behavioral-health facilities associated with the nonprofit partner, sometimes using the partner’s local name. This model combines Acadia’s specialized operating platform with the referral networks and institutional reputation of established hospitals. A significant turning point came in 2014, when Acadia acquired CRC Health from Bain Capital. CRC brought a large addiction-treatment platform and made opioid-treatment programs, including methadone clinics, an important part of Acadia’s portfolio. The company continued to expand this network, eventually becoming the largest methadone-clinic chain in the United States by the number of clinics described in late-2024 accounts. Its broader services include psychiatric hospitalization, residential treatment, outpatient care, counseling, medication management, and programs for trauma, eating disorders, and substance-use conditions. Acadia also pursued international growth. In June 2014 it bought Partnerships in Care in the United Kingdom, followed in May 2015 by the acquisition of mental-health assets from Care UK. Its expansion and proposed involvement with Priory Group prompted review by the UK Competition and Markets Authority. In October 2016, Acadia sold 22 behavioral-health facilities to BC Partners for £320 million. This divestiture reduced competition concerns and marked a limit on the company’s UK expansion strategy. During the 2020s, Acadia remained one of the largest pure-play behavioral-health operators in the United States. A 2022 description attributed approximately 22,500 employees, a daily patient census of about 70,000, and 242 facilities with approximately 10,800 beds across 39 states and Puerto Rico. Later descriptions cited more than 225 facilities, including more than 50 inpatient psychiatric hospitals in 19 states and 165 methadone clinics in 33 states. Counts differ according to reporting date and whether partnerships, outpatient sites, and other operating locations are included. The company’s expansion has occurred alongside persistent legal, regulatory, and ethical criticism. In 2019, it paid $17 million to resolve federal allegations concerning Medicaid billing for blood and urine tests. Its former Desert Hills facility in New Mexico closed after sexual-abuse revelations, followed by several lawsuits. In 2023, Acadia agreed to a $400 million settlement resolving three cases connected to alleged abuse at the facility, without admitting liability. In Utah, Highland Ridge Hospital was placed under progressively expanded independent monitoring in 2024 after safety violations and was subsequently scheduled for closure. Acadia’s treatment and admission practices have also been criticized by patients, employees, regulators, journalists, and legislators. Allegations have included unnecessary involuntary detention, inadequate staffing, improper billing, deficient safety controls, and incentives that favor occupancy and revenue over patient welfare. A 2024 Senate committee investigation criticized Acadia’s treatment of children, while the Securities and Exchange Commission announced a $19.84 million settlement concerning alleged legal violations and a separate $1.39 million whistleblower-related penalty. A December 2024 investigation into methadone operations reported alleged record falsification and excessive counselor caseloads. In February 2025, Acadia announced the closure of Timberline Knolls in Illinois after allegations of employee misconduct and related litigation. These controversies remain important to understanding the gap between Acadia’s scale and its public scrutiny.

1. 2025Timberline Knolls closure announced

   Acadia announced the closure of Timberline Knolls in Illinois amid misconduct allegations and legal challenges.

   Source
2. 2024Highland Ridge oversight and closure plan

   Utah regulators increased independent monitoring of Highland Ridge Hospital after safety violations; Acadia later announced plans to close it.

   Source
3. 2024SEC settlement

   Acadia agreed to a $19.84 million SEC settlement and received a separate $1.39 million whistleblower-related penalty.

   Source
4. 2023New Mexico abuse-case settlement

   Acadia agreed to a $400 million settlement resolving three lawsuits related to alleged abuse at Desert Hills, without admitting liability.

   Source
5. 2022Network expansion

   Acadia opened a children's hospital in Chicago, a Knoxville joint venture, and two comprehensive treatment centers.

   Source
6. 2019Desert Hills closes

   Acadia closed the Desert Hills facility in New Mexico after sexual-abuse revelations.

   Source
7. 2016UK facility divestiture

   Acadia sold 22 behavioral-health facilities to BC Partners for £320 million after UK competition scrutiny.

   Source
8. 2015Care UK asset acquisition

   The company acquired mental-health assets from Care UK.

   Source
9. 2014CRC Health acquisition

   Acadia acquired CRC Health from Bain Capital, substantially expanding its addiction-treatment and methadone-clinic operations.

   Source
10. 2014UK expansion begins

    Acadia acquired Partnerships in Care, a British mental-health and social-care provider.

    Source
11. 2011Initial public offering

    Acadia became a publicly traded company under the ticker ACHC.

    Source
12. 2005Company founded

    Reeve B. Waud founded Acadia Healthcare as a private behavioral-health company.

    Source

A large-scale, facility-based behavioral healthcare operator combining psychiatric treatment, addiction services, opioid-treatment programs, and hospital-system partnerships.

• Inpatient psychiatric hospitalsBehavioral healthcare

  Acadia operates inpatient psychiatric hospitals for patients requiring intensive evaluation, stabilization, medication management, nursing, therapy, and structured supervision. Facilities serve children, adolescents, and adults and may address acute psychiatric conditions, trauma, suicidal thoughts, behavioral crises, or co-occurring substance-use disorders. Some hospitals operate through partnerships with nonprofit health systems and use local partner branding.

• Addiction-treatment programsSubstance-use treatment

  Acadia provides treatment for alcohol- and drug-use disorders through inpatient, residential, partial-hospitalization, intensive outpatient, and outpatient formats. Programs may combine medical assessment, counseling, peer support, relapse-prevention planning, psychiatric care, and medication-assisted treatment. The exact service mix varies across facilities and jurisdictions.

• Methadone and opioid-treatment clinicsOpioid-use-disorder treatment2014

  Through the CRC Health platform and subsequent expansion, Acadia operates opioid-treatment programs offering methadone and related clinical and counseling services. These clinics are designed for people with opioid-use disorder and generally provide recurring medication administration, monitoring, counseling, and care coordination. By late 2024, public accounts described 165 clinics in 33 states.

• Outpatient behavioral healthcareMental-health services

  Outpatient services allow patients to receive behavioral-health care without continuous hospitalization. Depending on the site, offerings can include psychiatric assessment, individual and group therapy, medication management, intensive outpatient programs, partial hospitalization, crisis follow-up, and continuing-care support. These services extend Acadia’s model beyond hospital beds and residential settings.

• Specialized behavioral-health programsSpecialty care

  Acadia’s network includes specialized programs for eating disorders, trauma, post-traumatic stress, adolescent and children's mental health, and other complex behavioral conditions. Treatment may be delivered in dedicated hospitals, residential programs, or outpatient settings. Program scope, admission criteria, and clinical methods differ by facility.

• Skip the ER

  United States

  Acadia has marketed direct presentation to its behavioral-health facilities as an alternative to first visiting a nonprofit hospital emergency room. The approach promotes direct access for people experiencing mental-health crises and is supported by referral relationships with emergency departments and first responders.

  Source

• 2025Close Timberline KnollsOther

  The Illinois treatment facility faced allegations of employee misconduct and related legal challenges.

  What changed. Acadia announced the closure of Timberline Knolls in Lemont, Illinois.

  Source
• 2024Close Highland Ridge HospitalOther

  Utah regulators increased independent monitoring after reported safety violations.

  What changed. Acadia announced plans to close the Midvale facility.

  Source
• 2022Open new behavioral-health facilitiesProduct launch

  Acadia continued expanding capacity for child and adult behavioral-health treatment.

  What changed. It opened a children's hospital in Chicago, a Knoxville joint venture, and two comprehensive treatment centers.

  Aftermath. The openings increased the company’s facility-based treatment capacity.

  Source
• 2016Divest UK behavioral-health facilitiesM&A

  The UK Competition and Markets Authority investigated competition concerns related to Acadia’s expansion and Priory Group.

  What changed. Acadia sold 22 behavioral-health facilities to BC Partners.

  Aftermath. The divestiture addressed competition concerns and reduced Acadia’s UK facility holdings.

  Sale price. £320 million (October 2016)

  Source
• 2014Acquire CRC HealthM&A

  Acadia sought to expand beyond psychiatric facilities into addiction treatment and opioid-use-disorder care.

  What changed. It purchased CRC Health from Bain Capital.

  Aftermath. The transaction made addiction treatment and methadone clinics a major component of Acadia’s U.S. network.

  Source

• 2025Timberline Knolls misconduct allegationsControversy

  Acadia announced closure of Timberline Knolls after allegations involving employee misconduct and lawsuits brought by former patients, including allegations of sexual assault.

  Source
• 2024Highland Ridge safety violationsControversy

  Utah officials required independent monitoring at Highland Ridge Hospital after safety violations and later increased the monitoring requirement. Acadia announced the facility would close.

  Source
• 2024Senate report on child safety and incentivesControversy

  Senate Finance and HELP committees concluded that Acadia and another for-profit provider endangered children and argued that revenue-focused incentives contributed to inadequate safety and treatment. The findings were disputed in the broader public debate over behavioral-health facility oversight.

  Source
• 2024SEC enforcement settlementControversy

  The SEC settlement addressed allegations including billing for medically unnecessary inpatient services and conduct that restricted whistleblowers from reporting concerns.

  Source
• 2024Methadone-clinic investigationControversy

  A New York Times investigation reported alleged falsification of medical records used for billing, treatment of some patients who allegedly lacked opioid addiction, and counselor caseloads above certain state limits.

  Source
• 2023Desert Hills litigation settlementControversy

  Acadia reached a $400 million settlement resolving three lawsuits connected to alleged abuse at Desert Hills, without admitting liability.

  Source
• 2019Medicaid billing allegationsControversy

  Federal prosecutors in West Virginia alleged that Acadia overbilled Medicaid for blood and urine tests. The company paid $17 million to resolve the allegations.

  Source
• 2019Abuse allegations at Desert HillsControversy

  Acadia closed its former Desert Hills facility in New Mexico after revelations of sexual abuse. Several lawsuits followed, including litigation brought on behalf of minors.

  Source

• 2022Acadia expands behavioral-health network

  The company opened a children's hospital in Chicago, a joint-venture facility in Knoxville, and two comprehensive treatment centers.

  Product launch
  Source
• 2016UK competition review leads to facility divestitures

  The UK Competition and Markets Authority examined competition issues involving Acadia’s acquisition of Priory Group; Acadia later sold 22 behavioral-health facilities to BC Partners.

  RegulationM&A
  Source
• 2015Acadia acquires Care UK mental-health assets

  Acadia acquired mental-health assets from Care UK as part of its expansion in Britain.

  M&A
  Source
• 2014Acadia acquires CRC Health

  Acadia purchased CRC Health from Bain Capital, entering and rapidly expanding its opioid-treatment and methadone-clinic operations.

  M&A
  Source
• 2014Acadia expands into the United Kingdom through Partnerships in Care

  The company acquired Partnerships in Care, a British provider of mental-health and social-care services.

  M&A
  Source

1. Acadia Healthcare
2. Acadia Healthcare official website
3. The New York Times